P1219: ZANUBRUTINIB, LENALIDOMIDE PLUS R-CHOP (ZR2-CHOP) AS THE FIRST-LINE TREATMENT FOR NON-GCB DIFFUSED LARGE B-CELL LYMPHOMA (DLBCL)

• H. Zhu,
• Y. Sha,
• Y. Miao,
• S. Qin,
• W. Wu,
• J. Qiu,
• H. Mi,
• Y. Yang,
• C. Peng,
• C. Ding,
• Z. Wang,
• L. Fan,
• W. Xu,
• J. Li

Affiliations

H. Zhu

1 Department of Hematology, The First Affiliated Hospital of Nanjing Medical University

Y. Sha

1 Department of Hematology, The First Affiliated Hospital of Nanjing Medical University

Y. Miao

1 Department of Hematology, The First Affiliated Hospital of Nanjing Medical University

S. Qin

1 Department of Hematology, The First Affiliated Hospital of Nanjing Medical University

W. Wu

1 Department of Hematology, The First Affiliated Hospital of Nanjing Medical University

J. Qiu

2 Department of Hematology, Pukou CLL Center, Pukou division of Jiangsu Province Hospital

H. Mi

2 Department of Hematology, Pukou CLL Center, Pukou division of Jiangsu Province Hospital

Y. Yang

2 Department of Hematology, Pukou CLL Center, Pukou division of Jiangsu Province Hospital

C. Peng

2 Department of Hematology, Pukou CLL Center, Pukou division of Jiangsu Province Hospital

C. Ding

3 Department of Nuclear Medicine

Z. Wang

4 Department of Pathology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

L. Fan

1 Department of Hematology, The First Affiliated Hospital of Nanjing Medical University

W. Xu

1 Department of Hematology, The First Affiliated Hospital of Nanjing Medical University

J. Li

1 Department of Hematology, The First Affiliated Hospital of Nanjing Medical University